Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach

Abroad (travel likely)Recruiting

Conditions

Transgender · Gut Microbiome · Immune System · Cardiovascular Risk Factors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Experimental and Clinical Research Center, Clinical Research Unit, Berlin, Germany
Contact: Study coordinator (Michael Boschmann, MD) · michael.boschmann@charite.de · +4930450540241
Contact: Study coordinator (Lajos Marko, MD, PhD) · lajos.marko@charite.de · +4930450540144
Contact: Principal Investigator (Lajos Marko, MD, PhD)

Study leads

Sofia Forslund, Dr.
Study Director
Max-Delbrück-Center
Lajos Marko
Principal Investigator
Charite - Universitätsmedizin Berlin

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons

Meningococcal Meningitis, Serogroup B · Transgender Persons · Sex Differences in Immune Response

Abroad (travel likely)RecruitingPHASE4

Ghent, Belgium

Progesterone in Gender Affirming Hormone Therapy Study

Transgender Women

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States

Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System

Transsexualism · Transgenderism · Adiposity

Abroad (travel likely)Recruiting

Leipzig, Germany

Evaluating Sexual Functioning in Trans Men During the Gender Affirmation Process: A Mixed Methods Study

Sexual Functioning · Transgender Men · Gender Affirmation Surgery

Abroad (travel likely)Recruiting

Eskişehir, Turkey (Türkiye)